Bayesian Capital Management’s Affirm AFRM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$206K Buy
+4,500
New +$260K 0.25% 114
2025
Q2
Sell
-35,418
Closed -$1.6M 520
2025
Q1
$1.6M Buy
+35,418
New +$2.1M 0.26% 110
2024
Q4
Sell
-88,200
Closed -$3.6M 661
2024
Q3
$3.6M Buy
+88,200
New +$2.93M 0.42% 49
2024
Q2
Sell
-55,800
Closed -$2.08M 698
2024
Q1
$2.08M Buy
+55,800
New +$2.23M 0.2% 149
2023
Q4
Sell
-315,579
Closed -$6.71M 714
2023
Q3
$6.71M Buy
+315,579
New +$5.77M 0.77% 22
2022
Q4
Sell
-22,700
Closed -$426K 750
2022
Q3
$426K Buy
+22,700
New +$594K 0.09% 321
2022
Q2
Sell
-27,749
Closed -$1.28M 756
2022
Q1
$1.28M Buy
+27,749
New +$1.45M 0.19% 153

Other funds holding AFRM

Bayesian Capital Management's AFRM Position: Q1 2026 in Review

Bayesian Capital Management opened a new position in Affirm (AFRM) in Q1 2026: 4,500 shares worth $206K. The stake represents 0.25% of the portfolio and ranks #114 among its holdings. This is a return to the name: Bayesian Capital Management previously reported a position in AFRM as recently as Q1 2025.

Bayesian Capital Management first reported a position in AFRM in Q1 2022 and has held it in 7 quarters since. The position peaked at $6.71M in Q3 2023. 591 funds tracked by Wall St. Rank hold AFRM as of Q1 2026.

  • Bayesian Capital Management held 4,500 shares of Affirm worth $206K as of Q1 2026.
  • Affirm was a new Bayesian Capital Management position in Q1 2026.
  • Affirm made up 0.25% of Bayesian Capital Management's portfolio in Q1 2026, its #114 holding.
  • Bayesian Capital Management first reported a position in Affirm in Q1 2022 and has held it in 7 quarters since.
  • Bayesian Capital Management's Affirm position peaked at $6.71M in Q3 2023.
  • 591 funds tracked by Wall St. Rank held Affirm as of Q1 2026.

Based on Bayesian Capital Management's 13F filing for Q1 2026, filed 15 May 2026.